2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Neoplasms
47
Breast Neoplasms
32
Colorectal Neoplasms
28
Prostatic Neoplasms
27
Lung Neoplasms
17
Hematopoietic and Lymphatic System Neoplasm
13
Hematologic Neoplasms
12
Ovarian Neoplasms
11
Uterine Cervical Neoplasms
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Multiple Myeloma
7
Lymphoma
7
Leukemia
7
Head and Neck Neoplasms
6
Endometrial Neoplasms
6
Depression
6
Rectal Neoplasms
5
Pancreatic Neoplasms
5
Leukemia, Myeloid, Acute
5
Urinary Bladder Neoplasms
4
Mouth Neoplasms
4
Motor Activity
4
Melanoma
4
Malignant Solid Neoplasm
4
Hematopoietic and Lymphoid System Neoplasm
4
Gastrointestinal Neoplasms
4
Colonic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Anxiety Disorders
4
Advanced Cancer
4
Interventions
selpercatinib
3
Sorafenib
3
cabozantinib
2
Thyroid (USP)
2
Sodium
2
Radiofrequency Ablation
2
Metformin
2
Data Collection
2
vandetanib
1
tomivosertib
1
temsirolimus
1
repotrectinib
1
pralsetinib
1
pembrolizumab
1
lenvatinib
1
binimetinib
1
apatinib
1
acetaminophen, codeine drug combination
1
Watchful Waiting
1
Vitamin B 12
1
Tramadol
1
Thyroxine
1
Thyrotropin-Releasing Hormone
1
Thyroidectomy
1
Technetium Tc 99m Sestamibi
1
Surgical Procedures, Operative
1
Pemetrexed
1
Panobinostat
1
Observation
1
Negative-Pressure Wound Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thyroid Diseases
×
Interviews as Topic
×
Clear all
NCT06236373
2024-12-09
Survivorship
University of Modena and Reggio Emilia
Recruiting
45 enrolled